276 related articles for article (PubMed ID: 33433723)
1. Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal.
Wilson LL; Chakraborty S; Eans SO; Cirino TJ; Stacy HM; Simons CA; Uprety R; Majumdar S; McLaughlin JP
Cell Mol Neurobiol; 2021 Jul; 41(5):1131-1143. PubMed ID: 33433723
[TBL] [Abstract][Full Text] [Related]
2. Lyophilized Kratom Tea as a Therapeutic Option for Opioid Dependence.
Wilson LL; Harris HM; Eans SO; Brice-Tutt AC; Cirino TJ; Stacy HM; Simons CA; León F; Sharma A; Boyer EW; Avery BA; McLaughlin JP; McCurdy CR
Drug Alcohol Depend; 2020 Nov; 216():108310. PubMed ID: 33017752
[TBL] [Abstract][Full Text] [Related]
3. Effects of alkaloid-rich extract from Mitragyna speciosa (Korth.) Havil. on naloxone-precipitated morphine withdrawal symptoms and local field potential in the nucleus accumbens of mice.
Cheaha D; Reakkamnuan C; Nukitram J; Chittrakarn S; Phukpattaranont P; Keawpradub N; Kumarnsit E
J Ethnopharmacol; 2017 Aug; 208():129-137. PubMed ID: 28687506
[TBL] [Abstract][Full Text] [Related]
4. Physiological dependence to mitragynine indicated by a rapid cross-dependence procedure with heroin-dependent mice.
Yue K; Katz JL; Shu X
Psychopharmacology (Berl); 2022 Mar; 239(3):897-908. PubMed ID: 35107609
[TBL] [Abstract][Full Text] [Related]
5. The effects of chronic mitragynine (Kratom) exposure on the EEG in rats.
Suhaimi FW; Hassan Z; Mansor SM; Müller CP
Neurosci Lett; 2021 Feb; 745():135632. PubMed ID: 33444671
[TBL] [Abstract][Full Text] [Related]
6. The effects of mitragynine and morphine on schedule-controlled responding and antinociception in rats.
Hiranita T; Leon F; Felix JS; Restrepo LF; Reeves ME; Pennington AE; Obeng S; Avery BA; McCurdy CR; McMahon LR; Wilkerson JL
Psychopharmacology (Berl); 2019 Sep; 236(9):2725-2734. PubMed ID: 31098655
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic and clinical assessment of kratom.
White CM
Am J Health Syst Pharm; 2018 Mar; 75(5):261-267. PubMed ID: 29255059
[TBL] [Abstract][Full Text] [Related]
8. Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine.
Hemby SE; McIntosh S; Leon F; Cutler SJ; McCurdy CR
Addict Biol; 2019 Sep; 24(5):874-885. PubMed ID: 29949228
[TBL] [Abstract][Full Text] [Related]
9. Assessing physiological dependence and withdrawal potential of mitragynine using schedule-controlled behaviour in rats.
Harun N; Johari IS; Mansor SM; Shoaib M
Psychopharmacology (Berl); 2020 Mar; 237(3):855-867. PubMed ID: 31832720
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of mitragynine, an alkaloid with analgesic effect from Thai medicinal plant Mitragyna speciosa, on electrically stimulated contraction of isolated guinea-pig ileum through the opioid receptor.
Watanabe K; Yano S; Horie S; Yamamoto LT
Life Sci; 1997; 60(12):933-42. PubMed ID: 9061050
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the rewarding effects of mitragynine and 7-hydroxymitragynine in an intracranial self-stimulation procedure in male and female rats.
Behnood-Rod A; Chellian R; Wilson R; Hiranita T; Sharma A; Leon F; McCurdy CR; McMahon LR; Bruijnzeel AW
Drug Alcohol Depend; 2020 Oct; 215():108235. PubMed ID: 32889450
[TBL] [Abstract][Full Text] [Related]
12. Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2.
Váradi A; Marrone GF; Palmer TC; Narayan A; Szabó MR; Le Rouzic V; Grinnell SG; Subrath JJ; Warner E; Kalra S; Hunkele A; Pagirsky J; Eans SO; Medina JM; Xu J; Pan YX; Borics A; Pasternak GW; McLaughlin JP; Majumdar S
J Med Chem; 2016 Sep; 59(18):8381-97. PubMed ID: 27556704
[TBL] [Abstract][Full Text] [Related]
13. Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users.
Singh D; Yeou Chear NJ; Narayanan S; Leon F; Sharma A; McCurdy CR; Avery BA; Balasingam V
J Ethnopharmacol; 2020 Mar; 249():112462. PubMed ID: 31816368
[TBL] [Abstract][Full Text] [Related]
14. Mitragynine (Kratom)-Withdrawal behaviour and cognitive impairments can be ameliorated by an epigenetic mechanism.
Yunusa S; Müller CP; Hassan Z
Br J Pharmacol; 2024 Jul; 181(13):2070-2084. PubMed ID: 38523471
[TBL] [Abstract][Full Text] [Related]
15. Comparative Pharmacokinetics of Mitragynine after Oral Administration of Mitragyna speciosa (Kratom) Leaf Extracts in Rats.
Avery BA; Boddu SP; Sharma A; Furr EB; Leon F; Cutler SJ; McCurdy CR
Planta Med; 2019 Mar; 85(4):340-346. PubMed ID: 30452072
[TBL] [Abstract][Full Text] [Related]
16. Kratom Alkaloids as Probes for Opioid Receptor Function: Pharmacological Characterization of Minor Indole and Oxindole Alkaloids from Kratom.
Chakraborty S; Uprety R; Daibani AE; Rouzic VL; Hunkele A; Appourchaux K; Eans SO; Nuthikattu N; Jilakara R; Thammavong L; Pasternak GW; Pan YX; McLaughlin JP; Che T; Majumdar S
ACS Chem Neurosci; 2021 Jul; 12(14):2661-2678. PubMed ID: 34213886
[TBL] [Abstract][Full Text] [Related]
17. Antinociception, tolerance and withdrawal symptoms induced by 7-hydroxymitragynine, an alkaloid from the Thai medicinal herb Mitragyna speciosa.
Matsumoto K; Horie S; Takayama H; Ishikawa H; Aimi N; Ponglux D; Murayama T; Watanabe K
Life Sci; 2005 Nov; 78(1):2-7. PubMed ID: 16169018
[TBL] [Abstract][Full Text] [Related]
18. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice.
Matsumoto K; Takayama H; Narita M; Nakamura A; Suzuki M; Suzuki T; Murayama T; Wongseripipatana S; Misawa K; Kitajima M; Tashima K; Horie S
Neuropharmacology; 2008 Aug; 55(2):154-65. PubMed ID: 18550129
[TBL] [Abstract][Full Text] [Related]
19. Abuse liability of mitragynine assessed with a self-administration procedure in rats.
Yue K; Kopajtic TA; Katz JL
Psychopharmacology (Berl); 2018 Oct; 235(10):2823-2829. PubMed ID: 30039246
[TBL] [Abstract][Full Text] [Related]
20. Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of
Gerak LR; Minervini V; Latham E; Ghodrati S; Lillis KV; Wooden J; Disney A; Husbands SM; France CP
J Pharmacol Exp Ther; 2019 Nov; 371(2):507-516. PubMed ID: 31439807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
